bioRxivCancer Biology
Sperm-specific COX6B2 Enhances Oxidative Phosphorylation, Proliferation, and Survival in Lung Adenocarcinoma
C.-C. Cheng, J. Wooten, Z. Gibbs, K. McGlynn, P. Mishra, A. Whitehurst
Abstract
Cancer testis antigens (CTAs) are genes whose expression is normally restricted to the testis but anomalously activated in cancer. In sperm, a number of CTAs promote energy generation, however whether these proteins contribute to tumor cell metabolism is not understood. Here we describe COX6B2, a sperm-specific component of cytochrome c oxidase (complex IV). COX6B2 is frequently expressed in human lung adenocarcinoma (LUAD) and expression correlates with reduced survival time in patients. COX6B2, but not its somatic isoform COX6B1, enhances activity of complex IV, increasing mitochondrial oxidative phosphorylation (OXPHOS) and NAD+ generation. Consequently, COX6B2-expressing cells display a proliferative advantage, particularly in low oxygen conditions. Conversely, depletion of COX6B2 attenuates OXPHOS and collapses mitochondrial membrane potential leading to cell death or senescence. Furthermore, COX6B2 is both necessary and sufficient for growth of tumors in vivo. Our findings reveal a previously unappreciated, tumor specific metabolic pathway hijacked from one of the most ATP-intensive processes in the animal kingdom: sperm motility.
- organism: human
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- research focus: metabolism & bioenergetics
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- approach: experimental assay
- approach: genetic perturbation / CRISPR
- approach: biophysical modeling
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer
C. Y. Mah, A. D. T. Nguyen, … L. M. Butler·bioRxiv·Nov 5, 2022
- Oxidative Phosphorylation Inhibition in Different Prostate Cancer Models and the Interplay with Androgen Receptor Signaling
Minas Sakellakis, Sumankalai Ramachandran, … Mark Anton Titus·bioRxiv·Sep 23, 2024
- Viability of HepG2 and MCF-7 Cells is not Correlated with Mitochondrial Bioenergetics
J. Doczi, N. Karnok, … C. Chinopoulos·Scientific ReportsPeer-reviewed·Jul 4, 2023
- Setd2 inactivation sensitizes lung adenocarcinoma to inhibitors of oxidative respiration and mTORC1 signaling
D. M. Walter, A. C. Gladstein, … D. M. Feldser·bioRxiv·Oct 6, 2022
- Limits of aerobic metabolism in cancer cells
Alexei Vazquez·bioRxiv·Jun 5, 2015
- Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across tumor types
I. Boykov, M. Montgomery, … K. Fisher-Wellman·bioRxiv·Jun 4, 2023